MACROPHAGE ACTIVATION SYNDROME
Clinical trials for MACROPHAGE ACTIVATION SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MACROPHAGE ACTIVATION SYNDROME trials appear
Sign up with your email to follow new studies for MACROPHAGE ACTIVATION SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug trial aims to tame deadly dengue inflammation
Disease control OngoingThis study is testing whether a drug called anakinra can help people hospitalized with severe dengue fever. Dengue can cause a dangerous overreaction of the immune system called a 'cytokine storm.' Researchers want to see if anakinra, which calms inflammation, can improve organ f…
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
Scientists dig through old records to make new cancer treatments safer
Knowledge-focused OngoingThis study aims to learn from the past to make future cancer treatments safer. Researchers are reviewing the medical records of 500 children and adults who received immunotherapies, like CAR T-cell therapy, to understand their side effects. The goal is to identify patterns and ri…
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC